<code id='44ABABE8E7'></code><style id='44ABABE8E7'></style>
    • <acronym id='44ABABE8E7'></acronym>
      <center id='44ABABE8E7'><center id='44ABABE8E7'><tfoot id='44ABABE8E7'></tfoot></center><abbr id='44ABABE8E7'><dir id='44ABABE8E7'><tfoot id='44ABABE8E7'></tfoot><noframes id='44ABABE8E7'>

    • <optgroup id='44ABABE8E7'><strike id='44ABABE8E7'><sup id='44ABABE8E7'></sup></strike><code id='44ABABE8E7'></code></optgroup>
        1. <b id='44ABABE8E7'><label id='44ABABE8E7'><select id='44ABABE8E7'><dt id='44ABABE8E7'><span id='44ABABE8E7'></span></dt></select></label></b><u id='44ABABE8E7'></u>
          <i id='44ABABE8E7'><strike id='44ABABE8E7'><tt id='44ABABE8E7'><pre id='44ABABE8E7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:81
          a stethoscope and money – hospitals and health insurance coverage from STAT
          Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

          Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

          Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

          advertisement

          Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Belarusian journalist sentenced to 4 years in prison as crackdown continues
          Belarusian journalist sentenced to 4 years in prison as crackdown continues

          TALLINN,Estonia--ABelarusianjournalistwassentencedFridaytofouryearsinprisonafterbeingconvictedofaidi

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          UnitedHealth wins $3.3 billion takeover of Amedisys

          UnitedHealthGroup’sOptumwillpay$3.3billiontotalforthehomehealthgiantAmedisys.JimMone/APHomehealthand